Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C R Antonescu

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2016
A phase II study of axitinib (AG-013736) in patients with incurable adenoid cystic carcinomaA L Ho, L Dunn, E J Sherman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 2011
Advanced well-differentiated/dedifferentiated liposarcomas: role of chemotherapy and survivalA Italiano, M Toulmonde, A Cioffi, et al.
Oncogene|March 13, 2001
The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25M Ladanyi, M Y Lui, C R Antonescu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcomaE de Alava, A Kawai, J H Healey, et al.
ESMO Open|July 27, 2025
A phase I study of the CSF1R inhibitor vimseltinib in combination with the PD-L1 inhibitor avelumab in patients with advanced sarcomaE Rosenbaum, K Seier, M Bradic, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 6, 2020
Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma NetworkG D Demetri, C R Antonescu, B Bjerkehagen, et al.
ESMO Open|June 5, 2021
Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of expertsS Stacchiotti, A B Miah, A M Frezza, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2016
A phase II study of axitinib (AG-013736) in patients with incurable adenoid cystic carcinomaA L Ho, L Dunn, E J Sherman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 2011
Advanced well-differentiated/dedifferentiated liposarcomas: role of chemotherapy and survivalA Italiano, M Toulmonde, A Cioffi, et al.
Oncogene|March 13, 2001
The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25M Ladanyi, M Y Lui, C R Antonescu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcomaE de Alava, A Kawai, J H Healey, et al.
ESMO Open|July 27, 2025
A phase I study of the CSF1R inhibitor vimseltinib in combination with the PD-L1 inhibitor avelumab in patients with advanced sarcomaE Rosenbaum, K Seier, M Bradic, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 6, 2020
Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma NetworkG D Demetri, C R Antonescu, B Bjerkehagen, et al.
ESMO Open|June 5, 2021
Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of expertsS Stacchiotti, A B Miah, A M Frezza, et al.
Pageof 5